INmune Bio Inc (INMB) is a biotechnology company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Use this INMB page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the INMB quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the INMB SEC filings page. Lician reads the product cache first so this HTML stays unique to INmune Bio Inc even when a live quote feed is slow.
Latest cached year on this hub. Full INMB income, balance, and cash tables.